These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 15306778)
1. Petition fails to reverse massive price rise for AIDS drug. Check E Nature; 2004 Aug; 430(7001):715. PubMed ID: 15306778 [No Abstract] [Full Text] [Related]
2. AIDS drug price hike prompts calls for intervention. Check E Nature; 2004 May; 429(6987):6. PubMed ID: 15129244 [No Abstract] [Full Text] [Related]
3. Patents. NIH declines to march in on pricing AIDS drug. Malakoff D Science; 2004 Aug; 305(5686):926. PubMed ID: 15310867 [No Abstract] [Full Text] [Related]
4. Intellectual property. NIH weighs demand to force sharing of AIDS drug patents. Malakoff D Science; 2004 Jun; 304(5676):1427-9. PubMed ID: 15178775 [No Abstract] [Full Text] [Related]
5. Ethics and AIDS drugs. Dowell W Time; 1999 Jul; 154(2):49. PubMed ID: 10538646 [No Abstract] [Full Text] [Related]
6. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries. Spectar JM Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914 [No Abstract] [Full Text] [Related]
7. No money, no meds. Mabry M Newsweek; 1999 Jul; 134(2):32-3. PubMed ID: 10538648 [No Abstract] [Full Text] [Related]
8. France wins larger share of patent royalties after AIDS test dispute. Macilwain C Nature; 1994 Jul; 370(6485):85. PubMed ID: 8022487 [No Abstract] [Full Text] [Related]
9. AIDS activists fail to block 'reasonable pricing' reform. Gavaghan H Nature; 1995 Jan; 373(6512):272. PubMed ID: 7830751 [No Abstract] [Full Text] [Related]
11. Drug prices: real problem, wrong solution. Kennedy D Science; 2001 Jun; 292(5523):1797. PubMed ID: 11397914 [No Abstract] [Full Text] [Related]
12. Drug patent protection: how long is long enough? Sibbald B CMAJ; 2001 May; 164(9):1331. PubMed ID: 11341146 [No Abstract] [Full Text] [Related]
13. Gore's humanitarianism loses out to strong-arm tactics. Nature; 1999 Jul; 400(6739):1. PubMed ID: 10403233 [No Abstract] [Full Text] [Related]
14. The Affordable Prescription Drugs Act: a solution for today's high prescription drug prices. Pinzone JD J Law Health; 2001-2002; 16(1):145-68. PubMed ID: 14650775 [No Abstract] [Full Text] [Related]
15. Global AIDS trial denied patients as US balks at generic drug use. Check E Nature; 2004 Sep; 431(7008):493. PubMed ID: 15457219 [No Abstract] [Full Text] [Related]
16. Lowering the cost of prescription drugs. Jindal B J La State Med Soc; 2003; 155(1):51. PubMed ID: 12656276 [No Abstract] [Full Text] [Related]
17. AIDS vaccine 'needs focused effort' as drug firms back off research. Butler D Nature; 1995 Nov; 378(6555):323-4. PubMed ID: 7477355 [No Abstract] [Full Text] [Related]
18. NIH denies march-in rights on Norvir patent. Harrison C Nat Rev Drug Discov; 2013 Dec; 12(12):898. PubMed ID: 24287772 [No Abstract] [Full Text] [Related]
19. Striking the right balance between innovation and drug price competition: putting the Hatch-Waxman Act into perspective. Deal JB Food Drug Law J; 1999; 54(2):185-6. PubMed ID: 11759712 [No Abstract] [Full Text] [Related]
20. Striking the right balance between innovation and drug price competition: understanding the Hatch-Waxman Act--an introduction of speakers. Rea TS Food Drug Law J; 1999; 54(2):223-5. PubMed ID: 11759713 [No Abstract] [Full Text] [Related] [Next] [New Search]